Published in Circulation on January 10, 2005
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98
Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail (2009) 3.95
Preventing 30-day hospital readmissions: a systematic review and meta-analysis of randomized trials. JAMA Intern Med (2014) 2.60
Effects of self-management intervention on health outcomes of patients with heart failure: a systematic review of randomized controlled trials. BMC Cardiovasc Disord (2006) 2.36
Relationship between literacy, knowledge, self-care behaviors, and heart failure-related quality of life among patients with heart failure. J Gen Intern Med (2011) 1.64
A propensity matched study of the association of education and outcomes in chronic heart failure. Int J Cardiol (2007) 1.62
Patients with Complex Chronic Diseases: perspectives on supporting self-management. J Gen Intern Med (2007) 1.20
Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study. Heart (2006) 1.16
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol (2008) 1.15
The effect of progressive, reinforcing telephone education and counseling versus brief educational intervention on knowledge, self-care behaviors and heart failure symptoms. J Card Fail (2011) 1.11
Identifying keys to success in reducing readmissions using the ideal transitions in care framework. BMC Health Serv Res (2014) 1.11
Exercise training in aging and diseases. Transl Med UniSa (2012) 1.11
Adequate health literacy is associated with higher heart failure knowledge and self-care confidence in hospitalized patients. J Cardiovasc Nurs (2011) 1.11
What do we know about adherence and self-care? J Cardiovasc Nurs (2008) 1.06
Symptom clusters of heart failure. Res Nurs Health (2009) 1.06
Quality and cost analysis of nurse staffing, discharge preparation, and postdischarge utilization. Health Serv Res (2011) 1.05
The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure. Pharm World Sci (2010) 0.97
Medication Adherence Interventions Improve Heart Failure Mortality and Readmission Rates: Systematic Review and Meta-Analysis of Controlled Trials. J Am Heart Assoc (2016) 0.91
The dilemma, causes and approaches to avoid recurrent hospital readmissions for patients with chronic heart failure. Heart Fail Rev (2012) 0.89
Recommendation of low-salt diet and short-term outcomes in heart failure with preserved systolic function. Am J Med (2009) 0.88
Regardless of age: Incorporating principles from geriatric medicine to improve care transitions for patients with complex needs. J Gen Intern Med (2014) 0.84
Telemedical support in patients with chronic heart failure: experience from different projects in Germany. Int J Telemed Appl (2010) 0.83
Educational needs for improving self-care in heart failure patients with diabetes. Diabetes Educ (2012) 0.82
Cost-effectiveness and cost-utility of a structured collaborative disease management in the Interdisciplinary Network for Heart Failure (INH) study. Clin Res Cardiol (2014) 0.81
Predictors of medication nonadherence differ among black and white patients with heart failure. Res Nurs Health (2015) 0.80
Impact of prior admissions on 30-day readmissions in medicare heart failure inpatients. Mayo Clin Proc (2014) 0.80
Hospital readmission in heart failure, a novel analysis of a longstanding problem. Heart Fail Rev (2015) 0.79
What components of chronic care organisation relate to better primary care for coronary heart disease patients? An observational study. BMJ Open (2012) 0.79
Medication knowledge of patients hospitalized for heart failure at admission and after discharge. Patient Prefer Adherence (2016) 0.77
Healthcare resource use among heart failure patients in a randomized pilot study of a cognitive training intervention. Heart Lung (2013) 0.76
How effective is an in-hospital heart failure self-care program in a Japanese setting? Lessons from a randomized controlled pilot study. Patient Prefer Adherence (2016) 0.76
Patient perceptions of nurse mentors facilitating the Aussie Heart Guide: A home-based cardiac rehabilitation programme for rural patients. Nurs Open (2015) 0.75
Short-Term Costs and Hospitalization Rates in Patients With Adult Congenital Heart Disease After Pulmonic Valve Replacement. Am J Cardiol (2016) 0.75
An integrative literature review on nursing interventions aimed at increasing self-care among heart failure patients. Rev Lat Am Enfermagem (2015) 0.75
Reducing Heart Failure Hospital Readmissions: A Systematic Review of Disease Management Programs. Cardiol Res (2014) 0.75
A Strategy to Reduce Heart Failure Readmissions and Inpatient Costs. Cardiol Res (2015) 0.75
Strategies to Modify the Risk of Heart Failure Readmission: A Systematic Review and Meta-Analysis. Health Serv Res Manag Epidemiol (2017) 0.75
Sodium restriction in heart failure: benefit or harm? Curr Treat Options Cardiovasc Med (2014) 0.75
Joint Commission requirements for discharge instructions in patients with heart failure: is understanding important for preventing readmissions? J Card Fail (2014) 0.75
Survey of experiences of an e-mentorship program: Part II. Clin J Oncol Nurs (2012) 0.75
Effect of standard versus patient-targeted in-patient education on patients' anxiety about self-care after discharge from cardiovascular surgery clinics. Cardiovasc J Afr (2014) 0.75
Challenges in acute heart failure clinical management: optimizing care despite incomplete evidence and imperfect drugs. Crit Pathw Cardiol (2015) 0.75
Systolic heart failure: knowledge gaps, misconceptions, and future directions. Ochsner J (2014) 0.75
Optimized treatment and heart rate reduction in chronic heart failure. Arq Bras Cardiol (2013) 0.75
Cardiology Consultation in the Emergency Department Reduces Re-hospitalizations for Low-Socioeconomic Patients with Acute Decompensated Heart Failure. Am J Med (2017) 0.75
Early Rehospitalization After Prolonged Intensive Care Unit Stay Post Cardiac Surgery: Outcomes and Modifiable Risk Factors. J Am Heart Assoc (2017) 0.75
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure. Korean Circ J (2017) 0.75
Effect of acute coronary syndrome patients' education on adherence to dual antiplatelet therapy. J Saudi Heart Assoc (2017) 0.75
Nurses' attitudes and behaviors on patient medication education. Pharm Pract (Granada) (2017) 0.75
Caregiver Integration During Discharge Planning for Older Adults to Reduce Resource Use: A Metaanalysis. J Am Geriatr Soc (2017) 0.75
Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med (2007) 7.15
Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol (2009) 4.03
Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol (2010) 3.63
Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation (2005) 3.48
Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol (2011) 3.06
Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J (2002) 2.95
Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol (2005) 2.38
The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol (2008) 2.37
Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol (2003) 2.35
HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. J Heart Lung Transplant (2013) 1.96
The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail (2010) 1.87
The cost of medical management in advanced heart failure during the final two years of life. J Card Fail (2008) 1.71
Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation (2010) 1.44
Vitamin D and cardiovascular disease. Pharmacotherapy (2009) 1.28
Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation (2007) 1.21
Device exchange after primary left ventricular assist device implantation: indications and outcomes. Ann Thorac Surg (2012) 1.18
Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. J Heart Lung Transplant (2010) 1.11
Barriers to constraining health care cost growth. Health Aff (Millwood) (2004) 1.07
Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure. Am J Cardiol (2005) 1.05
Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure. Am Heart J (2004) 1.05
The prevalence and pattern of complementary and alternative supplement use in individuals with chronic heart failure. J Card Fail (2005) 1.04
Six-minute walk distance predicts 30-day readmission in hospitalized heart failure patients. Arch Med Res (2010) 0.96
Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). J Clin Pharmacol (2003) 0.92
Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers. J Heart Lung Transplant (2004) 0.91
Risk of death associated with nesiritide in patients with acutely decompensated heart failure. JAMA (2006) 0.89
Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) trial. Eur J Heart Fail (2009) 0.89
Delayed sternal closure does not increase late infection risk in patients undergoing left ventricular assist device implantation. J Heart Lung Transplant (2012) 0.89
Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation. Ann Thorac Surg (2013) 0.88
Relationship between improvements in heart failure patient disease specific knowledge and clinical events as part of a randomized controlled trial. Patient Educ Couns (2011) 0.87
The effect of Crataegus oxycantha Special Extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure. Eur J Heart Fail (2008) 0.86
Antihypertensive drug development: current challenges and future opportunities. J Am Soc Hypertens (2010) 0.85
Heart failure prognostic models: why bother? Circ Heart Fail (2012) 0.85
Neurocognitive assessments in advanced heart failure patients receiving continuous-flow left ventricular assist devices. J Heart Lung Transplant (2009) 0.84
Relation of body mass index to mortality after development of heart failure due to acute coronary syndrome. Am J Cardiol (2009) 0.82
Baseline albumin is associated with worsening renal function in patients with acute decompensated heart failure receiving continuous infusion loop diuretics. Pharmacotherapy (2013) 0.81
Prognostic impact of the addition of peak oxygen consumption to the Seattle Heart Failure Model in a transplant referral population. J Heart Lung Transplant (2012) 0.81
Right-sided heart failure: diagnosis and treatment strategies. Curr Treat Options Cardiovasc Med (2008) 0.80
Left ventricular assist device management in patients chronically supported for advanced heart failure. Curr Opin Cardiol (2011) 0.80
Safety and efficacy of atorvastatin in heart transplant recipients. J Heart Lung Transplant (2002) 0.79
Diagnosis and management of right-sided heart failure in subjects supported with left ventricular assist devices. Curr Treat Options Cardiovasc Med (2010) 0.79
In vitro assessment of prosthesis type and pressure recovery characteristics: Doppler echocardiography overestimation of bileaflet mechanical and bioprosthetic aortic valve gradients. J Thorac Cardiovasc Surg (2012) 0.79
CRT-D therapy in heart failure: how much do NYHA class IV patients benefit? J Cardiovasc Electrophysiol (2006) 0.78
Impact of serial changes in cardiac hemodynamics on exercise performance in patients with heart failure due to ischemic and nonischemic cardiomyopathy. Am J Cardiol (2003) 0.78
Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy. Am J Cardiol (2003) 0.78
Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary. ASAIO J (2013) 0.77
Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements. J Heart Lung Transplant (2005) 0.77
Identification of device malfunction in patients supported with the HeartMate XVE left ventricular assist system. ASAIO J (2007) 0.77
The impact of patient-specific quality-of-care report cards on guideline adherence in heart failure. Am Heart J (2007) 0.77
Prophylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia. Am Heart J (2006) 0.76
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. Circ Heart Fail (2012) 0.76
Nesiritide for acute decompensated heart failure: does the benefit justify the risk? Curr Cardiol Rep (2007) 0.76
Sex matters, but to what clinical avail? Circ Heart Fail (2009) 0.75
Nesiritide--not verified. N Engl J Med (2005) 0.75
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. Circ Heart Fail (2012) 0.75
Outcomes After Concomitant Procedures with Left Ventricular Assist Device Implantation: Implications by Device Type and Indication. ASAIO J (2016) 0.75
Effect of oral vitamin E and C therapy on calcineurin inhibitor levels in heart transplant recipients. J Heart Lung Transplant (2005) 0.75
Medical and surgical treatment of chronic heart failure. Curr Probl Cardiol (2003) 0.75
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. J Heart Lung Transplant (2012) 0.75
Impact of left ventricular assist device on diabetes management: an evaluation through case analysis and clinical impact. Hosp Pract (1995) (2014) 0.75
Clinical Outcomes of Advanced Heart Failure Patients with Cardiogenic Shock Treated with Temporary Circulatory Support Before Durable LVAD Implant. ASAIO J (2015) 0.75
Relationship between obesity and resting energy expenditure in systolic heart failure. J Heart Lung Transplant (2010) 0.75
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. Ann Thorac Surg (2012) 0.75
Treating hypertension: a new chapter. Do whatever it takes to hit your blood-pressure target. Health News (2003) 0.75
The effectiveness of United Network of Organ Sharing status 2 transplantation in the modern era. J Heart Lung Transplant (2011) 0.75
Effect of obesity on in-hospital treatment for acute coronary syndrome complicated by new-onset heart failure. Coron Artery Dis (2013) 0.75
Left Lateral Thoracotomy for Centrifugal Continuous-Flow Left Ventricular Assist Device Placement: An Analysis from the Mechanical Circulatory Support Research Network. ASAIO J (2017) 0.75
Brugada syndrome in an active duty Air Force senior pilot. Mil Med (2008) 0.75
Percutaneous Driveline Fracture Following Implantation of the HeartMate II Left Ventricular Assist Device: How Durable is Driveline Repair? ASAIO J (2017) 0.75
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. Ann Thorac Surg (2012) 0.75
Adverse Event Rates Change Favorably Over Time for Patients Bridged With the HeartWare Left Ventricular Assist Device. ASAIO J (2017) 0.75
A restrictive inflow pattern does not predict implantable cardioverter-defibrillator therapy in primary prevention. Clin Cardiol (2009) 0.75
Impact of Patient Distance From Ventricular Assist Device-Implanting Center on Short- and Long-Term Outcomes. ASAIO J (2017) 0.75
Heart transplantation: assessment of heart failure mortality risk. Curr Heart Fail Rep (2007) 0.75